Adjunctive Granisetron Therapy in Patients With Sepsis or Septic Shock
Status:
Completed
Trial end date:
2020-12-28
Target enrollment:
Participant gender:
Summary
In this prospective, single-center,randomized,controlled,single-blind clinical trial,Patients
will be randomly assigned to receive granisetron or placebo for 4 days or until leaving the
ICU(death or transfer from ICU to general ward or discharge). The primary outcome is
all-cause death rate at 28 days.